Portfolio company
Peptilogics
United States · £61.6m raised
Raised
£61.6m
Latest stage
Series B
Rounds recorded
1
Backed by
6 investors
Sectors
About
This company develops engineered peptide therapeutics to treat and prevent medical device-related infections for patients undergoing joint replacements.
SourceFunding history · 1
Similar companies
Hyalex Orthopaedics
This company develops synthetic cartilage and implant systems to restore damaged joint surfaces for patients with osteoarthritis or cartilage injuries.
Semprus
This company develops antimicrobial surface coatings for medical device manufacturers to reduce infections and blood clots in patients using catheters or orthopaedic implants.
Amprologix
This biotechnology company develops novel antibiotics to treat antimicrobial-resistant bacterial infections for patients with conditions including MRSA and related skin and wound infections.
Moximed
This company develops implantable shock absorbers for patients with knee osteoarthritis to reduce joint load and delay the need for replacement surgery.
Mimetic Medicines
This company develops non-opioid peptide drug candidates for patients suffering from chronic pain.
MetalloBio
This company develops antimicrobial compounds and medical device coatings to combat antibiotic resistance for the pharmaceutical and healthcare sectors.
Atro Medical
This company develops synthetic meniscus prostheses to restore knee function and relieve pain for patients with chronic knee injuries.
Preimure
This company develops antimicrobial polymer coatings for metallic medical implants to prevent infections in orthopaedic and traumatology patients.
